Bam Labs Inc

Have updates for this profile? Please contribute data

= Subscriber Access Only

You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.

With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.

Bam Labs Inc - overview

Location

Campbell, CA-California, US

Primary Industry

Medical Devices & Equipment

About

BAM Labs, a subsidiary of Select Comfort, specializes in sleep technology, particularly the SleepIQ® feature integrated within Sleep Number® beds, enhancing personalized sleep experiences through real-time data. BAM Labs focuses on developing sleep-enhancing technologies and was acquired by Select Comfort in September 2015. The company is headquartered in Campbell, US. Rich Rifredi serves as both CEO and Founder, having previously led other ventures in the technology space.


BAM Labs specializes in the development and management of the SleepIQ® technology embedded in Sleep Number® beds. These products provide personalized insights and data about users' sleep patterns, enabling adjustments for optimal comfort. The offerings include various models of Sleep Number® beds that feature real-time tracking capabilities via an app. Their target clientele is health-conscious consumers who seek improved sleep quality and those facing specific sleep-related challenges.


Sales are conducted primarily through e-commerce platforms and selective retail partnerships across the United States, ensuring a broad reach for their products. BAM Labs generates revenue through direct-to-consumer sales of its Sleep Number® beds, which incorporate the proprietary SleepIQ® technology. Business transactions occur mainly through retail and online channels, allowing customization of orders. Additional revenue may come from subscription services related to enhanced features or accessories that complement the SleepIQ® experience.


The pricing strategy reflects the premium positioning of the Sleep Number® brand, appealing to consumers interested in tailored sleep solutions based on individual health insights. Following the acquisition in September 2015, BAM Labs plans to leverage recent funding of USD 3. 520 mn to enhance its product offerings, including the development of new SleepIQ® technology features. The company seeks to expand its market presence by targeting international markets, particularly in Europe and Asia, anticipated by 2026.


This strategic growth will utilize insights from funding to develop innovative sleep solutions and enhance customer engagement.


Primary Industry

Medical Devices & Equipment

Sub Industries

Medical Devices & Equipment, Biomaterials

Website

www.bamlabs.com

Verticals

IoT (Internet of Things)

Company Stage

Acquired

Total Amount Raised

Subscriber access only

Bam Labs Inc - deals

Deals TypeDeal StatusTarget (s)Deal DateInvestor(s)Seller(s)Deal size (Mn)Enterprise value (Mn)Post-money valuation (Mn)EBITDA multiple (x)Revenue multiple (x)Lead partner (s)
Trade SaleCompletedBam Labs Inc-
Unspecified RoundCompletedBam Labs Inc-
Unspecified RoundCompletedBam Labs Inc-
Unspecified RoundCompletedBam Labs Inc-
Unspecified RoundCompletedBam Labs Inc-

Displaying 1 - 5 of 8

Bam Labs Inc - employee data

Blurred Background

Want to see Employee Count?

Request a demo for full access to this profile.

GoingPro

Time to go Pro

Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.